Your browser doesn't support javascript.
loading
CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemia.
Neumann, Frank; Pfreundschuh, Michael; Preuss, Klaus D; Schormann, Claudia; Zwick, Carsten; Murawski, Niels; Kubuschok, Boris.
Afiliação
  • Neumann F; José Carreras Center for Immuno and Gene Therapy, Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
  • Pfreundschuh M; José Carreras Center for Immuno and Gene Therapy, Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
  • Preuss KD; José Carreras Center for Immuno and Gene Therapy, Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
  • Schormann C; José Carreras Center for Immuno and Gene Therapy, Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
  • Zwick C; José Carreras Center for Immuno and Gene Therapy, Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
  • Murawski N; José Carreras Center for Immuno and Gene Therapy, Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
  • Kubuschok B; José Carreras Center for Immuno and Gene Therapy, Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
Int J Cancer ; 137(5): 1076-84, 2015 Sep 01.
Article em En | MEDLINE | ID: mdl-25677163
Hyperphosphorylated paratarg-7 (pP-7) carrier state is the strongest and most frequent molecular risk factor for MGUS, multiple myeloma (MM) and Waldenström's macroglobulinemia (WM), inherited autosomal-dominantly and, depending on the ethnic background, found in up to one third of patients with MGUS/MM. Since P-7 is the antigenic target of paraproteins that do not distinguish between wtP-7 and pP-7, we investigated CD4(+) T-cell responses in pP-7(+) patients and controls. Peptides spanning amino acids 1-35 or 4-31 containing phosphorylated or nonphosphorylated serine17 were used for stimulation. CD4(+) cells from 9/14 patients (65%) showed a pP-7 specific HLA-DR restricted response. These results demonstrate that pP-7 specific CD4(+) cells can mediate help for pP-7 specific chronic antigenic stimulation of P-7 specific B cells, which might ultimately result in the clonal evolution of a B cell into MGUS/MM/WM producing a P-7 specific paraprotein. Prerequisites for pP-7 specific stimulation of CD4(+) cells appear to be both a pP-7 carrier state and an HLA-DR subtype able to present and recognize pP-7. Our results serve as an explanation for the exclusive autoimmunogenicity of the hyperphosphorylated variant of P-7 and for the different hazard ratios of pP-7 carriers from different ethnic origins to develop MGUS/MM/WM.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gamopatia Monoclonal de Significância Indeterminada / Linfócitos T CD4-Positivos / Macroglobulinemia de Waldenstrom / Proteínas de Membrana / Mieloma Múltiplo / Antígenos de Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gamopatia Monoclonal de Significância Indeterminada / Linfócitos T CD4-Positivos / Macroglobulinemia de Waldenstrom / Proteínas de Membrana / Mieloma Múltiplo / Antígenos de Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha